Private Advisor Group, LLC Palatin Technologies Inc Transaction History

Private Advisor Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$0.27 - $0.5 $730 - $1,353	-2,707 Reduced 18.41%	12,000 $3,000
Q4 2021 Feb 10, 2022	SELL	$0.34 - $0.86 $4,773 - $12,074	-14,040 Reduced 48.84%	14,707 $7,000
Q3 2021 Oct 14, 2021	BUY	$0.44 - $0.63 $5,728 - $8,202	13,020 Added 82.79%	28,747 $13,000
Q1 2021 Apr 22, 2021	BUY	$0.68 - $1.25 $693 - $1,275	1,020 Added 6.94%	15,727 $11,000
Q4 2020 Apr 01, 2021	BUY	$0.38 - $0.78 $5,588 - $11,471	14,707 New	14,707 $10,000
Q3 2020 Nov 02, 2020	SELL	$0.47 - $0.64 $1,272 - $1,732	-2,707 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.41 - $0.73 $1,109 - $1,976	2,707 New	2,707 $1,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.